McCormick: The Recipe and The Receipt

In every kitchen in America, there is a red-capped jar that nobody thinks about. McCormick black pepper. McCormick garlic powder. McCormick cinnamon. The brand is so ubiquitous it has become invisible — a pantry fixture as unremarkable as the shelf it sits on. McCormick controls roughly 20% of the U.S. spice market, and its flavor solutions division quietly seasons the meals served at fast-food chains, hotel restaurants, and hospital cafeterias across 150 countries.

The business earned $3.00 per share last year. It has beaten earnings estimates in three of its last four quarters. Its operating margin has climbed from 13.6% in fiscal 2022 to 16.0% in fiscal 2025 — a steady, unspectacular recovery that would make any consumer-staples investor nod approvingly.

And yet, the stock has fallen 39% from its 52-week high.

This is not a turnaround story about a broken product. McCormick's spices still work. This is a story about what happens when a 137-year-old spice company signs a $44.8 billion merger agreement with Unilever's food division, loads the combined entity with $15.7 billion in new debt, and does it all while tariffs threaten to add $140 million in annual costs to a business that cannot commercially grow its core ingredients domestically.

The recipe is fine. It is the receipt that is causing the pain.

Investment Council: MKC: 🟡 WAIT →

All current verdicts: The Verdict Board →

McCormick traded at $78.16 in June 2025. At the time, the bull case was simple: stable consumer-staples business, multi-year margin recovery, growing Flavor Solutions segment, and a pristine balance sheet that had served the company through acquisitions of Cholula, FONA, and Frank's RedHot.

Then three things happened in quick succession.

The tariff shock (October 2025–January 2026). The Trump administration's tariff policy hit McCormick harder than almost any other food company. Pepper, cinnamon, vanilla, turmeric, and most other spices cannot be commercially grown in the United States. McCormick's initial estimate of $90 million in annual tariff exposure ballooned to $140 million as IEEPA duties escalated. In January 2026, the company issued fiscal 2026 EPS guidance of $3.05–$3.13 — well below the $3.23 consensus. The stock dropped 5.5% in a single session. Multiple analysts downgraded; Deutsche Bank cut its target from $70 to $59.

The Unilever merger (March 31, 2026). McCormick announced it would combine with Unilever's Foods business — including Hellmann's, Knorr, and dozens of regional brands — in a transaction valuing the combined entity at $44.8 billion. The structure: Unilever shareholders would own 55.1% of the new company, McCormick shareholders 35%, and Unilever would retain a 9.9% stake. Unilever would also receive $15.7 billion in cash, funded by a bridge loan that would load the combined entity with a net debt-to-EBITDA ratio of nearly 4x. The stock fell 10% on the news.

The backlash (April–May 2026). Major Unilever investor Terry Smith exited his entire position — worth hundreds of millions of pounds — calling the deal an abandonment of operational focus in favor of "activist-driven break-ups." Shareholders on both sides have accused the companies of rushing the deal through without adequate votes. The combined entity's leverage has become the central objection.

The stock has not recovered.

Sources: McCormick 10-K filings (FY2022–FY2025), Q1 FY2026 8-K. Fiscal year ends November 30.

The numbers tell a clear story of recovery. After the 2022 margin trough — driven by commodity inflation, supply chain costs, and unfavorable product mix — McCormick has rebuilt operating margin by 2.4 percentage points over three fiscal years. The Consumer segment grew 2.7% in FY2025, driven by volume and product mix rather than price alone. The Flavor Solutions segment, which serves food manufacturers and restaurant chains, grew operating income 7% in Q4 2025.

In Q1 FY2026 (quarter ended February 28, 2026), the company reported $1.87 billion in revenue — beating estimates of $1.79 billion — and $0.66 adjusted EPS versus $0.61 expected. The McCormick de Mexico acquisition, completed in January 2026, contributed 13% to the sales increase. Organic growth was 1.2%.

Revenue CAGR over the past five fiscal years: 4.1%. Not spectacular. But for a consumer-staples company with 37%+ gross margins and nearly $1 billion in annual operating cash flow, it does not need to be.

McCormick is a food ingredients manufacturer, not a direct-to-consumer brand with heavy app-store or Trustpilot presence. The customer-voice landscape is structurally thin:

Important caveat on consumer-voice analysis. Unlike a Peloton, Lululemon, or Bumble — brands that generate hundreds or thousands of reviews per month — McCormick's consumer interaction surface is structurally limited. People do not review their black pepper. The 2 Trustpilot reviews and 3 PissedConsumer complaints do not constitute a statistically meaningful sample. Any investor thesis for MKC must be built on financial fundamentals and merger math, not consumer-sentiment trends.

Question: Is McCormick's post-2022 operating margin recovery a statistically significant trend?

Method: Mann-Kendall trend test on adjusted operating margin, FY2022–FY2025.

Data: 13.6% → 14.4% → 15.9% → 16.0% (four annual observations)

Result: tau = 1.000, p = 0.089

The trend is monotonically positive — every year's margin was higher than the prior year's. However, with only four data points, the Mann-Kendall test cannot reject the null at the 5% significance level. The trend is real in magnitude (+2.4 percentage points) but the sample is too short for conventional statistical confidence.

Confidence interval on the difference: Pre-inflection gross margin (FY2020–2022) averaged 36.9% (SD: 0.98). Post-inflection (FY2023–2025) averaged 37.8% (SD: 0.59). The +0.9 pp improvement is directionally positive but not statistically significant (Welch's t = 1.41, p = 0.158).

Translation for investors: The margin recovery is real — you can see it in every quarter's filing. But four years of data is not enough to distinguish from normal margin fluctuation. Watch FY2026 Q2 (reporting ~June 25) for the fifth data point.

Question: How far has the stock's decline diverged from the underlying earnings trajectory?

The stock has declined at $2.95 per month over the past 12 months, with an R² of 0.98 — nearly perfectly linear. Meanwhile, adjusted EPS grew 1.7%. The result is a 37-percentage-point divergence between earnings direction (+1.7%) and stock direction (−39.1%).

P/E at the 52-week high: 26.5x trailing earnings. P/E today: 15.9x. Forward P/E on FY2026 guidance: 15.4x. That is a 40% multiple compression — the most dramatic in McCormick's modern trading history. The stock trades at a 41% discount to its five-year average P/E of ~27x.

The numbers miss the psychological dimension of the Unilever merger.

McCormick shareholders are being asked to trade 100% ownership of a predictable, premium-multiple consumer-staples business for 35% ownership of a highly leveraged conglomerate combining McCormick's spice portfolio with Unilever's Hellmann's, Knorr, Marmite, and dozens of regional food brands. The combined entity will have approximately $20 billion in revenue and $15.7 billion in new debt.

The financial logic makes sense on paper: $300–600 million in annual cost synergies, global distribution scale, and a dominant position in flavors-and-condiments. The merged company would be the world's largest pure-play flavor business.

But the market is pricing the risk, not the synergy. Three specific concerns dominate:

Leverage. Net debt-to-EBITDA of ~4x is high for a consumer-staples company. McCormick's pre-merger balance sheet was clean. The bridge loan structure adds refinancing risk in a higher-rate environment.

Dilution. McCormick shareholders go from owning 100% of a $6.8 billion revenue company to 35% of a $20 billion revenue company. Whether that is dilutive or accretive depends entirely on synergy execution.

Governance. Both Unilever and McCormick shareholders have expressed dissatisfaction with the deal process. Terry Smith's exit is a high-profile signal of institutional skepticism. The shareholder vote — expected in H2 2026 — is not guaranteed to pass.

Recovering: Operating margin (13.6% → 16.0% over three years). Consumer segment volume (organic +2% in Q1 FY2026). Flavor Solutions profitability (+28% op income in Q1 FY2025). International expansion (McCormick de Mexico contributing 13% to Q1 revenue).

NOT recovering: Stock price (down 39%, nearly perfectly linear decline). Investor confidence in the Unilever merger (Terry Smith exit, shareholder backlash). Tariff exposure clarity ($140M impact, but Supreme Court struck IEEPA tariffs in Feb 2026; refund timeline uncertain).

Unknown: Whether the Unilever merger shareholder vote will pass (H2 2026). Regulatory outcome (EU, U.S. antitrust). Whether IEEPA tariff refunds will materially reduce the $140M burden. Whether private-label competitors will erode McCormick's share during the merger distraction.

Consumer-voice data is structurally thin. McCormick's product category generates negligible online review volume compared to consumer-tech or DTC brands. The 2 Trustpilot reviews and 3 PissedConsumer complaints are noise, not a sample. Any investor thesis for MKC must be built on financial fundamentals and merger math.

The merger introduces binary risk. If the deal closes as structured, McCormick shareholders own 35% of a $20B-revenue entity with 4x leverage. If the deal collapses, McCormick returns to standalone status at 15.4x forward P/E with a clean balance sheet and $3+ in growing EPS. The standalone scenario may be the better outcome for the stock price near-term.

The tariff wildcard. The U.S. Supreme Court struck down IEEPA tariffs on February 20, 2026, and the Court of International Trade ordered refunds on March 4, 2026. If McCormick recovers a significant portion of its $140M annual burden, the EPS guidance range becomes immediately conservative. This is the most underappreciated catalyst in the MKC story.

The operating margin trend is directionally strong but statistically underpowered. The Mann-Kendall test at p = 0.089 is close to significance but not there. One more quarter of 15.5%+ margins would substantially strengthen the case.

McCormick is not a traditional turnaround. The product is not broken. The brand is not in decline. The financials are improving. What is broken is the market's willingness to pay for those fundamentals — and the merger is the reason.

Bear case (25% probability): The Unilever merger closes as structured. Integration is messy. 4x leverage constrains investment. Synergies take 4–5 years. Stock drifts to $40–44.

Base case (45% probability): Merger closes on revised terms — lower leverage, better governance. Tariff refunds partially offset headwinds. Stock reaches $55–62 by mid-2027.

Bull case (30% probability): Merger collapses or is renegotiated. McCormick returns to standalone. Tariff refunds boost EPS above guidance. At 25x on $3.20+ EPS, stock re-rates to $75–80.

Now ($47.63): McCormick trades at 15.4x forward earnings — a 43% discount to its five-year average P/E of ~27x. The standalone business is generating $3+ in EPS, nearly $1B in operating cash flow, and growing margins. The risk-reward skews positive unless you assign high probability to worst-case merger integration.

June 25, 2026 — Q2 FY2026 earnings: The first earnings release to fully reflect tariff impacts and early merger-related costs. If operating margin holds above 15.5% and management provides any update on tariff refunds or merger vote timing, this is the re-rating catalyst.

H2 2026 — Shareholder vote: The merger cannot proceed without McCormick shareholder approval. The vote outcome is the binary event that resolves the stock's identity crisis: leveraged conglomerate or standalone compounder.

When McCormick reports Q2 on or around June 25, subscribers will get Turnaround Radar's instant analysis covering: (1) whether operating margin hit the 15.5% threshold that would push the Mann-Kendall trend toward statistical significance, (2) any management commentary on tariff refund timing from the IEEPA ruling, (3) the first concrete timeline for the shareholder vote, and (4) whether the stock's 40% multiple compression begins to unwind or deepens further.

That is when we will know whether the recipe can survive the receipt.

Investment Council: MKC: 🟡 WAIT →

All current verdicts: The Verdict Board →